171 related articles for article (PubMed ID: 28043913)
1. SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.
Li Y; Oliver PG; Lu W; Pathak V; Sridharan S; Augelli-Szafran CE; Buchsbaum DJ; Suto MJ
Cancer Lett; 2017 Mar; 389():41-48. PubMed ID: 28043913
[TBL] [Abstract][Full Text] [Related]
2. Small molecule modulators of Wnt/β-catenin signaling.
Mook RA; Chen M; Lu J; Barak LS; Lyerly HK; Chen W
Bioorg Med Chem Lett; 2013 Apr; 23(7):2187-91. PubMed ID: 23453073
[TBL] [Abstract][Full Text] [Related]
3. Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancer.
Teng Y; Wu R; Bo W; Tang M; Wang T; Cui X; Li Y; Zhang C; Ma Z; Fu Z; Xu Q; Liu J; Chen L
Eur J Med Chem; 2024 Mar; 268():116240. PubMed ID: 38422698
[TBL] [Abstract][Full Text] [Related]
4. The cholesterol biosynthesis enzyme FAXDC2 couples Wnt/β-catenin to RTK/MAPK signaling.
Madan B; Wadia SR; Patnaik S; Harmston N; Tan E; Tan IBH; Nes WD; Petretto E; Virshup DM
J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38488003
[TBL] [Abstract][Full Text] [Related]
5. An Underlying Mechanism of Dual Wnt Inhibition and AMPK Activation: Mitochondrial Uncouplers Masquerading as Wnt Inhibitors.
Zhang W; Sviripa VM; Kril LM; Yu T; Xie Y; Hubbard WB; Sullivan PG; Chen X; Zhan CG; Yang-Hartwich Y; Evers BM; Spear BT; Gedaly R; Watt DS; Liu C
J Med Chem; 2019 Dec; 62(24):11348-11358. PubMed ID: 31774672
[TBL] [Abstract][Full Text] [Related]
6. Asymmetrically Substituted Quadruplex-Binding Naphthalene Diimide Showing Potent Activity in Pancreatic Cancer Models.
Ahmed AA; Angell R; Oxenford S; Worthington J; Williams N; Barton N; Fowler TG; O'Flynn DE; Sunose M; McConville M; Vo T; Wilson WD; Karim SA; Morton JP; Neidle S
ACS Med Chem Lett; 2020 Aug; 11(8):1634-1644. PubMed ID: 32832034
[TBL] [Abstract][Full Text] [Related]
7. Retraction notice to "SRI36160 is a specific inhibitor of Wnt/-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48].
Li Y; Oliver PG; Lu W; Pathak V; Sridharan S; Augelli-Szafran CE; Buchsbaum DJ; Suto MJ
Cancer Lett; 2018 May; 422():131. PubMed ID: 29579438
[No Abstract] [Full Text] [Related]
8. Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
Zhang M; Wang Z; Zhang Y; Guo W; Ji H
J Med Chem; 2018 Apr; 61(7):2989-3007. PubMed ID: 29566337
[TBL] [Abstract][Full Text] [Related]
9. Retraction of "Design and Synthesis of Novel Cyclic Amine Benzimidazoles for the Treatment of Pancreatic Cancer".
Pathak V; Augelli-Szafran CE; Wei HX; Li Y; Oliver PG; Lu W; Buchsbaum DJ; Suto MJ
J Med Chem; 2017 Sep; 60(17):7615. PubMed ID: 28230988
[No Abstract] [Full Text] [Related]
10. Niclosamide: Beyond an antihelminthic drug.
Chen W; Mook RA; Premont RT; Wang J
Cell Signal; 2018 Jan; 41():89-96. PubMed ID: 28389414
[TBL] [Abstract][Full Text] [Related]
11. Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis.
Mook RA; Ren XR; Wang J; Piao H; Barak LS; Kim Lyerly H; Chen W
Bioorg Med Chem; 2017 Mar; 25(6):1804-1816. PubMed ID: 28233680
[TBL] [Abstract][Full Text] [Related]
12. Anthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mTOR inhibition.
Chen L; Wang L; Shen H; Lin H; Li D
Biochem Biophys Res Commun; 2017 Mar; 484(2):416-421. PubMed ID: 28137584
[TBL] [Abstract][Full Text] [Related]
13. Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells.
Che M; Kweon SM; Teo JL; Yuan YC; Melstrom LG; Waldron RT; Lugea A; Urrutia RA; Pandol SJ; Lai KKY
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32516943
[TBL] [Abstract][Full Text] [Related]
14. NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic cancer.
Zhou P; Li Y; Li B; Zhang M; Liu Y; Yao Y; Li D
Oncogene; 2019 Jul; 38(27):5500-5515. PubMed ID: 30967633
[TBL] [Abstract][Full Text] [Related]
15. SMARCAD1 Promotes Pancreatic Cancer Cell Growth and Metastasis through Wnt/β-catenin-Mediated EMT.
Liu F; Xia Z; Zhang M; Ding J; Feng Y; Wu J; Dong Y; Gao W; Han Z; Liu Y; Yao Y; Li D
Int J Biol Sci; 2019; 15(3):636-646. PubMed ID: 30745850
[TBL] [Abstract][Full Text] [Related]
16. Trefoil Factor 2 Regulates Proliferation and Apoptosis of Pancreatic Cancer Cells and LPS-Induced Normal Pancreatic Duct Cells by β-Catenin Pathway.
Zhou Y; Zhang Y; Wang J
Cancer Manag Res; 2020; 12():10705-10713. PubMed ID: 33149677
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of ANP32E is associated with poor prognosis of pancreatic cancer and promotes cell proliferation and migration through regulating β-catenin.
Zhang J; Lan Z; Qiu G; Ren H; Zhao Y; Gu Z; Li Z; Feng L; He J; Wang C
BMC Cancer; 2020 Nov; 20(1):1065. PubMed ID: 33148205
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer.
Fu X; Hong L; Yang Z; Tu Y; Xin W; Zha M; Tu S; Sun G; Li Y; Xiao W
J Cell Mol Med; 2020 Nov; 24(22):13020-13035. PubMed ID: 33026174
[TBL] [Abstract][Full Text] [Related]
19. Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition through the Wnt/β‑catenin pathway.
Wang C; Wei Y; Wang G; Zhou Y; Zhang J; Xu K
Oncol Rep; 2020 Aug; 44(2):711-721. PubMed ID: 32627022
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway.
Zhou Y; Hua Z; Zhu Y; Wang L; Chen F; Shan T; Zhou Y; Dai T
Cancer Cell Int; 2020; 20():225. PubMed ID: 32536813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
